Pharmafile Logo

New agency

- PMLiVE

Pharma’s growing ease with social media

GSK's participation last week in a Twitter chat is a sign of how comfortable the industry has become with social media

- PMLiVE

New hope for castration-resistant prostate cancer

An unprecedented number of therapies have reached late-stage clinical trials or been approved over recent years targeting this disease with an unmet medical need

- PMLiVE

Lilly launches diabetes partnership programme in South Africa

Partners with Project Hope and Donald Woods Foundation

Guide to selecting a healthcare comms agency

Whitepaper published by US agency White Space Healthcare Marketing

- PMLiVE

GSK’s malaria vaccine effects ‘modest’ in infants

Less than expected efficacy findings surprise researchers

- PMLiVE

Boehringer launches online education portal for hepatitis C

Comes as company moves its interferon-free hep C regimen into phase III

- PMLiVE

UK to use GSK’s Rotarix in rotavirus vaccination programme

Chosen ahead of Merck & Co’s RotaTeq

- PMLiVE

NICE rejects Pierre Fabre’s bladder cancer drug Javlor

Says drug received final draft 'no' because pharma company failed to prove efficacy

- PMLiVE

Boehringer moves interferon-free hep C regimen into phase III

Oral combination drug achieved viral cure rate of up to 85 per cent in phase IIb

- PMLiVE

Good practice in cancer care recognised at UK awards

Sir Mike Richards honoured with lifetime achievement award at QiC Excellence in Oncology 2012

- PMLiVE

AIMM Therapeutics appoints former Novartis VP Jan de Vries as CEO

Joined by John Womelsdorf who is appointed VP business development

- PMLiVE

Malaria charity calls up Ladbury PR to handle comms

Comes as Malaria No More UK partners with ITV’s I’m A Celebrity…Get Me Out Of Here

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links